IA
CHRS icon

IndexIQ Advisors’s Coherus Oncology CHRS Stock Holding History

IndexIQ Advisors’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-28,905
Closed -$461K – 1346
2021
Q4 		$461K Sell
28,905
-1,868
-6% -$32.7K 0.02% 640
2021
Q3 		$495K Buy
30,773
+3,082
+11% +$45.2K 0.02% 561
2021
Q2 		$383K Sell
27,691
-85
-0.3% -$1.2K 0.01% 786
2021
Q1 		$406K Buy
+27,776
New +$472K 0.01% 559

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

IndexIQ Advisors's CHRS Position: Q1 2022 in Review

IndexIQ Advisors sold out of Coherus Oncology (CHRS) in Q1 2022, closing a stake of 28,905 shares — an estimated $461K sold.

IndexIQ Advisors first reported a position in CHRS in Q1 2021 and held it in 4 quarters. The position peaked at $495K in Q3 2021. 183 funds tracked by Wall St. Rank hold CHRS as of Q1 2022.

  • IndexIQ Advisors reported no remaining Coherus Oncology position as of Q1 2022 after selling out during the quarter.
  • IndexIQ Advisors sold 28,905 Coherus Oncology shares in Q1 2022, an estimated $461K.
  • IndexIQ Advisors first reported a position in Coherus Oncology in Q1 2021 and held it in 4 quarters.
  • IndexIQ Advisors's Coherus Oncology position peaked at $495K in Q3 2021.
  • 183 funds tracked by Wall St. Rank held Coherus Oncology as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.